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© 2012 The Japan Society of Histochemistry and Recent studies have revealed that signals from neural crest (NC) derivatives regulate the
mass, proliferation, and maturation of beta cells in developing fetal pancreas. However, little
is known about the cellular distribution of NC derivatives during pancreatic development or
the process whereby the developing islets are enclosed. We studied the temporal and spatial
distribution of NC derivatives and endocrine cells at each developmental stage. At embryonic
day 10.5 (E10.5) of mouse embryo, NC derivatives that migrated to the prospective pancreatic
region were distributed in close proximity to pancreatic epithelial cells. As development
advanced, most NC derivatives progressively surrounded endocrine rather than exocrine
cells, and were distributed in closer proximity to alpha cells rather than to beta cells. At E20,
approximately 70% of the NC derivatives enclosing endocrine cells were distributed in close
proximity to alpha cells. Moreover, the expression of SynCAM, a Ca2+-independent homophilic
trans-cell adhesion molecule, was confirmed from E16.5 on and was more remarkable at
the cell boundaries of alpha cells and NC derivatives. These findings suggest that NC
derivatives might be distributed in close proximity to alpha cells as a result of homophilic
binding of SynCAM expressed by alpha cells and NC derivatives during islet development.
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I. Introduction
Islets of Langerhans are not just endocrine cell clusters
composed of alpha and beta cells, but comprise part of an
ectodermally-derived nervous system known to innervate
the islets during cell development in pancreas. It is therefore
presumed that the islets are multicellular complexes com-
prising endocrine cells that form aggregates with nervous
system components [25, 31], and constitute higher-order
endocrine units that maintain nutritional and blood glucose
homeostasis. Nerve signals are known to improve the
function of endocrine cells in adults [6, 11, 18, 26], but the
detailed functions of the ectodermally-derived cells enclos-
ing pancreatic islets, such as the functions of glial fibrillary
acidic protein (GFAP)- and S100-positive peri-islet Schwann
cells (PISCs) that surround nerve fibers around the islets
[5, 30, 34, 37], remain to be investigated. Although the
functional significance of PISCs in endocrine cells in adults
remains unclear, it is presumed that nerve-related cells
associated with the islets play a key role in protecting the
islets for the following reasons: (1) they are the first target
of the pathogenesis of type 1 diabetes, (2) their disruption
leads to a pathogenic cascade [36, 39], and (3) in a murine
model of islet injury type 2 diabetes, the PISCs of mice
treated with streptozotocin displayed reactive gliosis [35].
The first morphological indications of pancreatic
formation are observed around embryonic day 9.5 (E9.5) ofShimada et al. 66
the mouse embryo, with the appearance of ventral pancreatic
and dorsal buds in a specific portion of the intestinal tract
[10]. The pancreatic bud can be detected by the expression
of pancreatic and duodenal homeobox 1 (PDX1), which is
localized in endocrine cells as development proceeds. These
pancreatic buds grow, branch, differentiate, and eventually
merge to form the pancreas. As development proceeds, the
endocrine cells also differentiate and mature, and gradually
form aggregations that eventually merge to form pancreatic
islets. The development of the pancreas thus requires not
only pancreatic mesoderm and endoderm, but also innerva-
tion by ectodermally derived tissues, which occurs at E12.5
[2]. In a recent study, ectoderm-derived neural crest (NC)
derivatives were shown to accumulate in close proximity
to pancreatic epithelial cells at E10.0 [24]. NC cells are
pluripotent and mobile, and they differentiate into many
cell types, including peripheral and enteric neurons, glia,
melanocytes, and smooth muscle cells [9, 19, 20, 33, 40].
Signals from NC derivatives are also known to be essential
for the maturation of beta cells [24]. However, despite the
importance of NC derivatives in the development of
endocrine cells, little is known about the cellular distribution
of both NC derivatives and endocrine cells, or the process
whereby NC derivatives enclose the latter during the
development of the pancreas. Here, we report our examina-
tion of the temporal and spatial distribution of NC derivatives
and endocrine cells during the development of the pancreas
and our observations of the behavior of the NC derivatives
during the formation of pancreatic islets.
II. Materials and Methods
Animals
All experiments were performed in accordance with
the guidelines of the local ethics committee of the Jikei
University School of Medicine. Transgenic Wnt1-Cre
mice expressing Cre recombinase under control of the
Wnt1 promoter/enhancer [B6.Cg-Tg (Wnt1-Cre) 11Rth
Tg (Wnt1-GAL4) 11Rth/J] were mated with indicator mice
(CAG-CATloxP/loxP-EGFP)  [4,  16]  to  obtain  Wnt1-
Cre/Floxed-EGFP mice. Wnt1-Cre/Floxed-EGFP mice
express enhanced green fluorescent protein (EGFP) in all
NC cells and their derivatives. When a vaginal plug ap-
peared, the day was designated 0.5 days post-coitum. Wnt1-
Cre/Floxed-EGFP embryos were selected on the basis of
EGFP expression. Adult Wnt1-Cre/Floxed-EGFP mice were
selected for PCR-based genotyping with primers for the Cre
and CAT genes. The embryos used for the experiments were
collected at different developmental stages, which were
defined as follows: early stage pancreatic development,
E10.5–E12.0; mid-stage pancreatic development, E12.5–
E15.5; and late stage pancreatic development, E16.5–E20.
Immunohistochemistry
For histological analyses, samples were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS) at 4°C
overnight, soaked in different concentrations of sucrose/PBS
buffer (10, 20, and 30%) at 4°C for 1 hr, embedded in
Tissue-Tek OCT compound, and frozen. Frozen sections
Table 1. Primary and secondary antibodies for immunohistchemistry
Abcam: Cambridge, UK; Aves: Oregon, USA; Calbiochem: Darmstadt, Germany; Cell Signaling Technology: Danvers, USA; Dako: Copenhaven,
Denmark; Jackson ImmunoResearch: West Grove, PA, USA MBL: Nagoya, Japan; Millipore: Billerica, USA; Molecular Probes: Merelbeke,
Belgium; Sigma-Aldrich; St. Louis, MO, USA; Trans genic: Kumamoto, Japan.
primary and secondary antibody working dilution type source
green fluorescent protein (GFP) 1:1000 chick polyclonal Aves
green fluorescent protein (GFP) 1:1000 rabbit polyclonal Abcam
Insulin 1:500 guinea pig polyclonal Dako
Glucagon 1:2000 mouse monoclonal Sigma
Glucagon 1:200 rabbit polyclonal Cell Signaling Technology
Glial fibrillary acidic protein (GFAP) 1:500 rabbit polyclonal Dako
S100 1:1000 rabbit polyclonal Dako
neurofilament 160 kDa (NF-M) 1:1000 chick polyclonal Aves
tyrosine hydroxylase (TH) 1:1000 rabbit polyclonal Millipore
calcitonin gene-related peptide (CGRP) 1:2000 rabbit polyclonal Calbiochem
choline acetyltransferase (ChAT) 1:30 rabbit polyclonal Abcam
neuronal protein HuC/HuD 1:50 mouse monoclonal Molecular Probes
Pancreatic and duodenal homeobox 1 (PDX1) 1:400 rabbit polyclonal Trans Genic
SynCAM 1:500 chick polyclonal MBL
Alexa Fluor 488 1:1000 goat anti-rabbit, goat anti-chick, goat 
anti-guinea pig
Molecular Probes
Alexa Fluor 555 1:1000 goat anti-rabbit, streptoavidin 
conjugated
Molecular Probes
Alexa Fluor 633 1:1000 goat anti-rabbit, goat anti-guinea pig, 
streptoavidin conjugated
Molecular Probes
DyLight549 1:500 goat anti-chick Jackson ImmunoResearchNC Derivatives during Islet Development 67
(10-µm thick) were incubated with blocking solution (10%
normal goat serum plus 0.1% Tween-20 in PBS) at room
temperature for 10 min. Primary antibodies were diluted in
the antibody dilution buffer (1% normal goat serum plus
0.1% Triton-X100 in PBS), and incubated at 4°C overnight.
Primary and secondary antibodies used in this study are
described in Table 1. Biotinylated anti-mouse IgG reagent
(1:500, Vector: Burlingame, CA, USA) was used for mouse
on mouse staining, and the results were visualized using
streptavidin conjugated with Alexa555 or Alexa633 (1:500).
Nuclei were stained with 4,6-diamino-2-phenylindole
(DAPI) solution (1:1000, Dojindo: Kumamoto, Japan). The
immunostained samples were observed with a confocal laser
scanning microscope (LSM510 META, Carl Zeiss) and a
fluorescence microscope (Axio Imager, Axiocam, Carl
Zeiss).
III. Results
Islets enclosed by NC derivatives
In adult mice, the islets were surrounded by nerve
fibers, GFAP and S100-positive PISCs (Fig. 1A, B). These
Fig. 1. Neural crest (NC) derivatives surrounding islets differentiated into neural-related cells and tended to be distributed in closer proximity to
alpha cells. (A and B) Three-week-old mouse cells stained with neurofilament (NF-M) (green) (A), glial fibrillary acidic protein (GFAP)
(green) (B), insulin (blue) (A and B), and glucagon (red) (A and B) antibodies, showing immunoreactivity in regions surrounding the islets.
Most of the nerve-related cells tended to be located in closer proximity to alpha cells than to beta cells (arrows). (C) Constitutive expression of
enhanced green fluorescent protein (EGFP) in NC cells and their derivatives in double transgenic Wnt1-Cre/Floxed-EGFP mice. (D) Pancreatic
region of a 3-week-old Wnt1-Cre/Floxed-EGFP mouse; the cells were stained with insulin (blue), glucagon (red), and GFP (green) antibodies.
EGFP immunoreactivity is observed around the islets. Most NC derivatives tended to be located in closer proximity to alpha cells than to
beta cells (arrows). (E–J) To determine the cell types of NC derivatives differentiated into around islets, immunostaining experiments were
performed with various nerve-related and EGFP antibodies. Neural fibers (sympathetic nerves (G), parasympathetic nerves (H), and sensory
nerves (F)) surrounding the islets were found to be derived from NC cells. Moreover, pancreatic ganglion cells (I) that made contact with islets
were also found to be derived from NCs. peri-islet Schwann cells (PISCs) (J) surrounding the islets were also derived from NC cells. Bar=50
µm for all Figures. i=Islet.Shimada et al. 68
nerve-related cells surrounding the islets were assumed to
originate from the NC cells. We confirmed the types of cells
the NC derivatives differentiated into in the pancreas using
a transgenic mouse line that expresses EGFP in all NC cells
and their derivatives (Fig. 1C). NC derivatives were widely
distributed throughout the pancreas and were located
particularly close to blood vessels and the pancreatic islets.
Most of the NC derivatives enclosed the islets (Fig. 1D).
NC derivatives surrounding the islets primarily differentiated
into the nervous system (Figs. 1E–J). Moreover, most NC
derivatives were distributed in close proximity to alpha cells
located at the margins of the islets (Fig. 1A, B, and D;
arrows). Therefore, our data suggest that cell-cell inter-
actions may occur between the NC derivatives and alpha
cells. To investigate their physical relationship, the cellular
distribution of both NC derivatives and endocrine progenitor
cells during pancreatic development was examined further.
Relationship between endocrine progenitor cells and NC 
derivatives during pancreatic development
The localization of NC derivatives that migrated to the
pancreas was examined using Wnt1-Cre/Floxed-EGFP mice
at each developmental stage. The prospective area of the
pancreas was identified by the pancreatic epithelial marker
Fig. 2. Distribution of NC derivatives during pancreatic development. (A–L) Immunohistochemical staining of pancreatic regions of Wnt1-Cre/
Floxed-EGFP mouse embryos at each embryonic stage. Staining was performed with pancreatic and duodenal homeobox 1 (PDX1) antibody
(magenta) and GFP antibody (green). (A) At embryonic day 9.5 (E9.5), Wnt1-Cre/Floxed-EGFP embryos did not have any NC derivatives in
close proximity to the ventral and dorsal pancreatic buds (arrow). (B) At E10.5, NC derivatives were observed in a close proximity to both
pancreatic buds. They were closer to the dorsal pancreatic bud than to the ventral pancreatic bud (arrowheads). (C and D) From E11.0, NC
derivatives surrounded PDX1-positive cells. (E) At E12.5, as branching of buds progressed, NC derivatives were distributed along the
pancreatic epithelial cells. (F) At E14.5, several NC derivatives tended to be located close to cells with high PDX1 expression (arrows). (J–L)
Higher magnification image of the region in G–I, where NC derivatives were distributed in close proximity to PDX1-positive cells (arrows).
(M–O) Immunohistochemical staining of pancreatic regions of mouse embryos is shown; staining was performed with insulin antibody (blue),
glucagon antibody (red), and PDX1 antibody (green). During later stages of pancreatic development, PDX1-positive cells were mainly localized
in insulin-positive rather than glucagon-positive cells. Bar=100 µm (B–O). VB=ventral pancreatic bud, DB=dorsal pancreatic bud.NC Derivatives during Islet Development 69
PDX1, whereas NC derivatives were identified by EGFP
expression. At E9.5, NC derivatives were not observed in
proximity to the epithelia of the pancreatic buds (Fig. 2A;
arrow). However, at E10.5, NC derivatives were observed
in proximity to the epithelia of the ventral and dorsal
pancreatic buds (Fig. 2B). Most NC derivatives observed in
close proximity to the pancreatic buds were distributed
more on the dorsal side than on the ventral side (Fig. 2B;
arrowheads). Therefore, NC derivatives migrated to the
prospective region of the pancreas between E9.5–E10.5,
and were mostly distributed on the dorsal side of the
pancreatic bud. NC derivatives surrounded PDX1-positive
cells at E11.0 (Fig. 2C). Many of the NC derivatives in
the developing pancreas were scattered along branched
pancreatic epithelial cells from E11.5 (Fig. 2D, E). As
development advanced, NC derivatives were widely distrib-
uted throughout the developing pancreas (Fig. 2F–I). Some
of the NC derivatives were distributed in proximity to the
cells with a high PDX1 expression from the stage where
differentiation into endocrine cells began (Fig. 2F, J–L;
arrows). As development advanced, PDX1 expression
became localized in endocrine rather than in exocrine cells.
From E16.5, PDX1 expression was mainly localized in beta
cells, and most alpha cells were PDX1-negative (Fig. 2M–
Fig. 3. Glucagon-positive cells tended to be located between PDX1-positive cells and NC derivatives. (A–H) Immunohistochemical staining
of pancreatic regions of Wnt1-Cre/Floxed-EGFP mouse embryos during later stages of pancreatic development. Staining was performed with
PDX1 antibody (red) and GFP antibody (green), and nuclei were stained with DAPI solution (blue). (C, F, and I) Immunohistochemical
staining results with PDX1 antibody (red), GFP antibody (green), and glucagon antibody (white). Figures B, E, and H are higher magnification
images of A, D, and G, respectively. NC derivatives were distributed in closer proximity to PDX1-negative cells (arrowheads) than to
PDX1-positive cells (arrows). Figures C, F, and I represent the same sections as B, E, and H, respectively, but were stained with glucagon
antibody (white). PDX1-negative cells located in close proximity to NC derivative cells were glucagon-positive (arrows). Most NC derivatives
tended to be distributed in closer proximity to glucagon-positive cells than to PDX1-positive cells (arrowheads) during later stages of pancreatic
development. Bar=50 µm (A, D, G, C, F, and I).Shimada et al. 70
O). Therefore, in the late stage of pancreatic development,
some of the NC derivatives tended to be distributed in close
proximity to beta cells; this is different from the cellular
distribution of NC derivatives and endocrine cells in adults.
To investigate this difference, detailed distribution of both
NC derivatives and PDX1-positive cells in the later stages
of pancreatic development was examined further.
With development, most NC derivatives tended not to be in 
close proximity to PDX1-expressing cells
Immunostaining experiments to detect endocrine cells
and EGFP at the early stage of pancreatic development
indicated that a few NC derivatives tended to be distributed
in close proximity to endocrine cells (data not shown).
Moreover, from E14.5, some NC derivatives displayed a
tendency to approach cells with high PDX1 expression
(Fig. 2F, J–H; arrows). As pancreatic development ad-
vanced, only beta cells showed high PDX1 expression. Our
results, therefore, showed that the majority of cells with
high PDX1 expression have a beta-cell lineage. This supports
previous findings that signals from NC derivatives regulate
the mass, proliferation, and maturation of beta cells.
However, we also confirmed that NC derivatives were
distributed in closer proximity to alpha cells rather than beta
cells during the postnatal stages. During late-stage pancreatic
development, although NC derivatives were distributed in
close proximity to cells with high PDX1 expression (Fig. 3B
and H; arrowheads), several other cell types remained
present between the cells with high PDX1 expression and
the NC derivatives (Fig. 3B, E, H; arrows). Therefore, we
Fig. 4. Distribution of NC derivatives and endocrine cells during pancreatic development. (A–I) Immunohistochemical staining of pancreatic
regions of Wnt1-Cre/Floxed-EGFP mouse embryos during late embryonic stage. Staining was performed with insulin antibody (blue) (A, D,
and G) (magenta) (C, F, and I), glucagon antibody (RED) (A, D, and G) (magenta) (B, E, and H), and GFP antibody (green). (J) Pancreatic
region of an E18.5 Wnt1-Cre/Floxed-EGFP mouse embryo stained with insulin antibody (blue), glucagon antibody (red), and GFP antibody
(green) and the location of the 20-µm grid. From E16.5 on, NC derivatives tended to be distributed in closer proximity to alpha cells (arrows)
than to beta cells (arrowheads). To confirm the gradual process by which NC derivatives migrated into closer proximity to endocrine cells,
the characteristics of the cells that appeared in the 20-µm grid were examined based on the images obtained from the immunostaining
experiments in embryos from stages later than E14.5. The results were as follows: (1) as development of the pancreas advanced, the frequency
of the appearance of endocrine cells and NC derivatives in the same grid also increased (K); and (2) the frequency of the appearance of
glucagon-expressing cells and NC derivatives in the same grid also increased, indicating that alpha cells were in closer proximity to NC
derivatives than to beta cells (L). Therefore, as development advanced, the tendency for NC derivatives to be distributed in closer proximity to
alpha cells increased. Bar=100 µm (A–I).NC Derivatives during Islet Development 71
suggest that endocrine cells other than beta cells are present
between the cells with high PDX1 expression and the NC
derivatives. To identify these intervening cells, we examined
the cellular distribution of alpha cells, which are PDX1-
negative during late-stage pancreatic development. Most of
the intervening cells were identified as PDX1-negative alpha
cells (Fig. 3C, F, I; arrows). These results indicate that during
late-stage pancreatic development, alpha cells are found
between NC derivatives and cells with high PDX1 expres-
sion; hence, most NC derivatives distributed in close
proximity to the cells with high PDX1 expression do not
come into contact with beta cells directly (Fig. 3C, F, I;
arrows and arrowheads).
During late-stage pancreatic development, most NC 
derivatives tended to be distributed in close proximity to 
alpha cells
To investigate the cellular distribution of the NC
derivatives and of each endocrine cell type during pancreatic
development, we confirmed the cellular distribution of these
cells during late-stage pancreatic development. Immuno-
staining experiments at the early stage of pancreatic
development indicated that some NC derivatives tended to
be distributed in close proximity to endocrine cells (data
not shown). At E16.5, most NC derivatives tended to be
distributed in closer proximity to alpha cells (Fig. 4B;
arrows) than to beta cells (Fig. 4C; arrowheads). Moreover,
Fig. 5. SynCAM expression in the mouse pancreas. (A–F) Immunohistochemical staining of pancreatic regions of Wnt1-Cre/Floxed-EGFP
mouse embryos. Staining was performed with SynCAM antibody (green), glucagon antibody (blue), and PDX1 antibody (red). (G–L) Immuno-
histochemical staining of embryos at E12.5, E16.5 and 3W; staining was performed with GFP antibody (green), SynCAM antibody (RED), and
glucagon antibody (blue). At E12.5 and E14.0, all pancreatic epithelial cells and glucagon-positive cells were positive for SynCAM (A, B, D,
and E), but at E16.5, SynCAM expression was limited to the membranes of glucagon-positive cells and cells with high PDX1 expression (C and
F). In adult pancreas, SynCAM was mainly expressed by NC derivatives and alpha cells (G and H). At E16.5, SynCAM was expressed by
membranes of NC derivatives and glucagon positive cells (L). A similar SynCAM expression pattern was confirmed at E12.5 (I, J and K).
Bars=20 µm (A–C), 10 µm (D–F and J–L), 50 µm (I), 100 µm (G), 20 µm (H).Shimada et al. 72
as development advanced, this tendency was remarkably
increased (Fig. 4D–I). Therefore, we showed that NC
derivatives tended to approach alpha cells rather than beta
cells in the later stages of pancreatic development.
To confirm the gradual process whereby NC derivatives
moved closer to both endocrine cell types, the characteristics
of cells that appeared in a 20-µm grid were examined using
images obtained from the immunostaining experiments
performed during stages after E14.5 (Fig. 4J). The rate at
which the NC derivatives and endocrine cells were found
to co-exist in the same grid increased as the development
advanced. These results suggest that NC derivatives tended
to approach the endocrine cell region rather than the exocrine
cell region (Fig. 4K). Moreover, the NC derivatives enclos-
ing the endocrine cells were distributed in closer proximity
to alpha cells than to beta cells. At E16.5, approximately
60% of the NC derivatives enclosing endocrine cells were
distributed in close proximity to alpha cells. This ratio
increased to approximately 70% at E20. On the other hand,
the rate at which NC derivatives were distributed in close
proximity to beta cells was substantially decreased (Fig. 4L).
During late-stage pancreatic development, both alpha cells 
and NC derivatives expressed a common cell adhesion 
molecule (CAM)
Most NC derivatives were distributed in closer prox-
imity to alpha cells than to beta cells during islet develop-
ment. To investigate the cell-cell interactions between NC
derivatives and alpha cells, we confirmed the expression of
several CAMs. In adult mice, CADM-1, also referred to as
“SynCAM”, a Ca2+-independent homophilic trans-CAM,
was expressed by NC derivatives and the membranes of
alpha cells (Fig. 5G, H). During embryogenesis, we observed
the temporal and spatial expression of SynCAM in the
developing pancreas and confirmed that SynCAM was
expressed by the cell membranes of all pancreatic epithelial
cells  by  E14.0  (Fig. 5A,  B,  D,  E).  At  E12.5,  SynCAM  ex-
pression was confirmed in not only the cell membranes of
the pancreatic epithelial cells but also in the NC deriva-
tives (Fig. 5I–K). As development advanced, SynCAM
expression was limited to the NC derivatives, the cell
membranes of endocrine cells, PDX1-positive cells, and a
few exocrine cells (Fig. 5C, F, L). SynCAM expression by
both NC derivatives and alpha cells was confirmed from
E16.5 (Fig. 5L). Among the endocrine cells, the cell mem-
branes of most alpha cells expressed SynCAM, but almost
none of the cell membranes of beta cells did (Fig. 6A–C;
arrows). SynCAM expression in the pancreas was mainly
observed in the cell membranes of alpha cells and NC
derivatives (Fig. 7A–C, G–I, M–O; arrowheads). It was
also confirmed that the endocrine cells came into contact
with the NC derivatives. SynCAM expression by the cell
membranes of beta cells was barely detectable, and, when
present, was at the cell boundaries of interacting NC
derivatives and beta cells (Fig. 7D–F, J–L, P–R; arrowheads)
or alpha cells and beta cells (Fig. 6A–C; arrowheads).
SynCAM expression by the cell membranes of beta cells
that were not distributed in close proximity to NC derivatives
or alpha cells was either very weak or absent (Fig. 7F, L,
R; the section enclosed with dotted lines). Therefore,
SynCAM expression was confirmed from E16.5 on in areas
where NC derivatives came into contact with endocrine cells
(Fig. 7S). These results show that during the later stages of
pancreatic development, SynCAM expression is detected at
the cell boundaries between NC derivatives and alpha cells
as well as between NC derivatives and some beta cells.
Fig. 6. SynCAM expression between each endocrine cell type during late-stage of pancreatic development. (A–C) Immunohistochemical
staining of pancreatic regions of Wnt1-Cre/Floxed-EGFP mouse embryos during late development stage. Staining was performed with
SynCAM antibody (green), glucagon antibody (red), and insulin antibody (blue). (D–H) Immunoreactivity of SynCAM expression between
alpha cells and beta cells is shown. During later stages of pancreatic development, SynCAM was expressed at the cell boundaries between alpha
cells (1, 2, and 3 in A, B, and C) and between alpha cells and beta cells (7, 8, and 9 in A, B, and C). SynCAM expression was also confirmed
between the cell boundaries of a few beta cells (4, 5, and 6 in A, B, and C, respectively). Bar=10 µm for all Figures.NC Derivatives during Islet Development 73
IV. Discussion
Previous studies have shown that signals from NC
derivatives regulate the mass, proliferation, and maturation
of beta cells [21, 24]. In addition, it has previously been
shown that co-culturing pancreatic islets with NC stem cells
in vitro promotes the regeneration of functional beta cells
[22]. Therefore, it is believed that NC derivatives that
migrate to the pancreatic region are important for mainte-
nance of the function, development, and maturation of beta
cells. Our results relating to the cellular distribution of NC
derivatives at each stage of pancreatic development support
NC derivative signaling of beta cells. A previous study
indicated that such signals are likely to be juxtacrine signals,
because neural fibers derived from NC cells are located
close to insulin-positive cells at E15.5, and they contact with
98% of the insulin cell clusters by the first postnatal day
[24]. However, our results show that the NC derivatives
enclosing endocrine cells are located in closer proximity
to alpha cells than to beta cells from the later stages of
pancreatic development. Moreover, we showed that as
development advances, the ratio of NC derivatives distrib-
uted in close proximity to alpha cells increases remarkably.
Therefore, we suggest that the NC derivatives probably
signal beta cells using juxtacrine as well as paracrine signals
or a combination of both.
This tendency of NC derivatives to be distributed in
close proximity to a specific cell type is of interest as it
indicates that the NC derivatives that migrate to the
pancreatic region are not distributed at random during
pancreatic development. The structure of the islet cells might
be related to deviations in the cellular distribution of the
NC derivatives and each endocrine cell type at the embry-
onic stage. In rodents, the general structure of the islets is
for beta cells to occupy the center and alpha cells to be
distributed in the peripheral regions [23, 32]. We confirmed
that in adult mice, nerve fibers and nerve-related cells
tended to enclose the majority of islets. Therefore, we
believe that NC derivatives and endocrine cells might have
unique distributions during embryogenesis as a form of in
preparation for the highly-regimented organization of the
mature islets. Because NC derivatives tended to be distrib-
Fig. 7. SynCAM expression at the cell boundaries between NC derivatives and both endocrine cell types. (A–R) Immunohistochemical staining
of pancreatic regions of Wnt1-Cre/Floxed-EGFP mouse embryos during later stages of pancreatic development. Staining was performed with
SynCAM antibody (red), glucagon antibody (blue) (A, B, G, H, M, and N), insulin antibody (blue) (D, E, J, K, P, and Q), and GFP antibody.
During later stages of pancreatic development, most NC derivatives came into contact with endocrine cells (B, E, H, K, N, and Q; arrows).
SynCAM expression occurred at the cell boundaries between NC derivatives and endocrine cells (C, F, I, L, O, and R; arrowheads). The
majority of endocrine cells in which SynCAM was expressed were alpha cells. Beta cells that were in contact with NC derivatives were also
positive for SynCAM (F, L, R; arrowheads), but SynCAM expression was very weak or not expressed in beta cells distributed far away
from NC derivatives (F, L, R; the section enclosed with dotted lines). A schematic diagram of the cellular distribution of NC derivatives and
endocrine cells based on SynCAM expression pattern during later stages of pancreatic development (S). This schematic diagram shows that
SynCAM was expressed during interactions among alpha cells, NC derivative cells and endocrine cells, and between alpha cells and beta cells.
Bars=20 µm (A–R).Shimada et al. 74
uted in close proximity to endocrine cells from the fetal
stage, we hypothesized that the endocrine cells and NC
derivatives might use a common cellular adhesion system.
Moreover, because the NC derivatives were distributed in
closer proximity to alpha cells than to beta cells during
islet development, we believed that a cell-cell interaction
of these cell types would be important for unique cellular
distributions of the endocrine cells and NC derivatives, as
observed during islet development.
To investigate cell-cell interactions between the NC
derivatives and alpha cells during the later stages of
pancreatic development, we confirmed the expression of
several CAMs. Previous studies have proven the expression
of CAMs by endocrine cells [15, 28]. We focused on
CADM-1 (SynCAM), a Ca2+-independent CAM, because a
previous study showed that SynCAM mediates nerve-islet
cell interactions [17]. SynCAM has 3 immunoglobulin-like
motifs in its extracellular domain [29, 38] and is expressed
by a variety of cell types including epithelial and non-
epithelial cells [1, 12–14, 38]. Previous reports have shown
that SynCAM can interact with cells by homophilic binding,
such as that which occurs between neurons [1] or between
mast cells and neurons [8].
Our results suggest that homophilic binding of the
SynCAM expressed by endocrine cells and NC derivatives
contributes to endocrine cell-NC derivative interactions
during islet development. Moreover, during the later stages
of pancreatic development, NC derivatives are distributed
in closer proximity to alpha cells than to beta cells, and
SynCAM is also markedly expressed by NC derivatives and
alpha cells at that time point. On the other hand, SynCAM
expression was barely confirmed at the cell membranes of
beta cells distributed near NC derivatives and alpha cells.
Considering the results from previous studies as well as
those from our own SynCAM expression analysis, it appears
that SynCAM contributes to the aggregation of alpha cells
from embryogenesis. In contrast, it is assumed that SynCAM
does not contribute to the aggregation of beta cells. We
propose that a mechanism regulating homophilic binding of
SynCAM is responsible for the tendency of NC derivatives
to be distributed in closer proximity to alpha cells than to
beta cells. However, the structure of islets is also known to
be mediated by several other CAMs. For example, disruption
of neural CAM (NCAM) induces alpha cells to become
more randomly distributed within the islets [7], and dis-
ruption of E-cadherin (ECAD) also disrupts aggregation of
beta cells [3]. Although whether NCAM and ECAD disrup-
tions mediate NC derivative-endocrine cell interactions
remains unclear, we suggest that SynCAM is not the
primary mechanism behind endocrine cell-NC derivative
interactions; however, it is a mediating factor in NC
derivative-endocrine cell interactions during embryogenesis.
A recent study reported that sympathetic axon terminals
innervate alpha cells rather than beta cells in human islets,
which have a more complex structure than rodent islets [27].
It, therefore, appears that the cellular distribution of NC
derivatives that is associated with the relationship between
alpha cells and nerves is not due to the distinctive structure
of the rodent islets in which the beta cells occupy the center
and the alpha cells are distributed at the periphery. We
suggest that cell-cell interactions associated with specific
SynCAM expression in the fetal pancreas are one of the
factors by which the axon terminals innervate the alpha cells.
In conclusion, we elucidated the temporal and spatial
cellular distribution of NC derivatives and endocrine cells
during pancreatic development using Wnt1-Cre/Floxed-
EGFP mice. Our results strongly suggested that NC
derivatives are important for islet development and for the
differentiation and the maturation of endocrine cells because
NC derivatives tended to gradually approach the endocrine
cells during pancreatic development. Moreover, during the
later stages of pancreatic development, the NC derivatives
were distributed in closer proximity to alpha cells than to
beta cells. Analysis of SynCAM expression during islet
development indicated that NC derivatives might be distrib-
uted in closer proximity to alpha cells due to homophilic
binding between the SynCAM expressed by the alpha cells
and NC derivatives during islet development. Therefore,
we suggest that SynCAM is an important factor in the
relationship whereby alpha cells are distributed in the
proximity of NC derivatives in adults. It is, therefore, our
strong belief that interactions among NC derivatives, alpha
cells, and beta cells are all essential for the induction of a
physiologically competent islet, particularly from the point
of view of the development and regeneration of endocrines.
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